Comparison
17 20 Lyase Deficiency Isolated Included CN372394 vs 14q11 2 Microduplication Syndrome C4749855
Clinical comparison between 17 20 Lyase Deficiency Isolated Included CN372394 and 14q11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
6 comparison axes
Onset
17 20 Lyase Deficiency Isolated Included CN372394
0-16
14q11 2 Microduplication Syndrome C4749855
0-5
Onset patterns differ
Severity
17 20 Lyase Deficiency Isolated Included CN372394
severe
14q11 2 Microduplication Syndrome C4749855
moderate
Different severity levels
Chronic
17 20 Lyase Deficiency Isolated Included CN372394
Chronic
14q11 2 Microduplication Syndrome C4749855
Chronic
Differing course
Communicable
17 20 Lyase Deficiency Isolated Included CN372394
No
14q11 2 Microduplication Syndrome C4749855
No
Different transmission
Body System
17 20 Lyase Deficiency Isolated Included CN372394
endocrine
14q11 2 Microduplication Syndrome C4749855
congenital
Same/different system
Category
17 20 Lyase Deficiency Isolated Included CN372394
endocrine
14q11 2 Microduplication Syndrome C4749855
genetic
Different category
Bottom line
17-20-lyase-deficiency-isolated-included-CN372394 and 14q11-2-microduplication-syndrome-C4749855 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 17 20 Lyase Deficiency Isolated Included CN372394 | 14q11 2 Microduplication Syndrome C4749855 | Discriminating power |
|---|---|---|---|
| Sex-steroid development | May show undervirilization, atypical genitalia, or delayed puberty from impaired sex-steroid production. | Sex development is not the defining feature; findings, if present, are variable and nonspecific. | High |
| Developmental profile | Primary developmental delay is not established as a core feature. | Developmental delay may occur, but the pattern and severity vary widely. | Moderate |
| Age pattern | Concerns may emerge from birth through adolescence, especially around puberty. | Features are often recognized in early childhood, commonly before age 5. | Moderate |
When to favor each condition
Choose 17 20 Lyase Deficiency Isolated Included CN372394 when
Atypical genital development or absent puberty
These findings point toward an endocrine sex-steroid disorder rather than a chromosomal duplication.
Moderate
Steroid pathway abnormality suspected
Specialist endocrine and genetic testing can assess 17,20-lyase function without assuming a diagnosis.
Moderate
Severe chronic endocrine course
Supplied classification lists greater severity, but individual prognosis still requires clinical assessment.
Low
Choose 14q11 2 Microduplication Syndrome C4749855 when
Early developmental delay with congenital features
A chromosomal cause is more relevant when neurodevelopment is the main concern.
Moderate
Need for genomic structural testing
Microarray or equivalent testing can identify a 14q11.2 duplication.
High
Supportive developmental management
Care commonly emphasizes therapies and monitoring rather than hormone replacement alone.
Moderate
How key tests differ
| Test | 17 20 Lyase Deficiency Isolated Included CN372394 | 14q11 2 Microduplication Syndrome C4749855 | Interpretation |
|---|---|---|---|
| Steroid profile | May suggest reduced sex-steroid production with relatively preserved cortisol; exact cutoffs are not established here. | No characteristic steroid abnormality is established. | Abnormal steroids support endocrine evaluation but do not alone prove the diagnosis. |
| CYP17A1 or related genetic testing | May identify a causative variant when clinically indicated. | Not the primary test for a chromosomal microduplication. | Gene results require specialist interpretation and correlation with phenotype. |
| Chromosomal microarray | Not expected to define isolated lyase deficiency. | May detect an extra 14q11.2 segment. | A duplication finding needs clinical correlation because features vary. |
Prognosis comparison
17 20 Lyase Deficiency Isolated Included CN372394
- Outcome
- Often a chronic endocrine condition; long-term outcome depends on diagnosis, hormone needs, and puberty management.
- Factors
- Age at recognition, sex-development effects, and response to specialist care.
14q11 2 Microduplication Syndrome C4749855
- Outcome
- Often chronic with variable developmental impact; many needs are supportive rather than curative.
- Factors
- Extent of duplication effects, developmental profile, and access to therapies.
Time frame: Childhood through adolescence, with lifelong follow-up potentially needed.
Exact mortality and universal outcomes are not established from the supplied data.
Complications comparison
| Complication | Presentation |
|---|---|
| Pubertal or reproductive effects | Delayed puberty, infertility concerns, or sex-development differences may occur. Reproductive effects are not established as characteristic. Endocrine follow-up is important; outcomes vary. |
| Neurodevelopmental needs | Not established as a defining complication. Learning or developmental support needs may be substantial for some people. Assessment should be individualized. |
| Associated congenital variation | Genital differences may be present; broader congenital anomalies are not established. Additional congenital findings may occur but are variable. Neither condition has a uniform complication pattern in the supplied data. |
Patient education highlights
- HighDiagnosis is specialized
These are rare conditions. Test results should be explained by genetics and, when relevant, endocrinology clinicians.
- HighDifferent care focus
Lyase deficiency centers on hormone and sex-development care; microduplication care is mainly supportive and developmental.
- MediumVariable course
Severity and features differ between people. Avoid relying on a single symptom or online comparison.